CARDIOKINE
 
                    Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.
CARDIOKINE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cardiokine.com
Total Employee:
11+
Status:
Active
Contact:
215-399-1200
Email Addresses:
[email protected]
Total Funding:
87 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Content Delivery Network Apache JsDelivr BootstrapCDN Unified Layer Hostgator Mail
Similar Organizations

AMDL
AMDL is a biopharmaceutical company engaged in the development of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products.

EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

NovaDel Pharma Inc
NovaDel Pharma Inc., a specialty pharmaceutical company, develops oral spray formulations for marketed pharmaceuticals.
Poly Pharmaceuticals
POLY Pharmaceuticals, Inc. is a privately held company founded in 1980 by a group of pharmacists focused on developing and marketing branded

Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List


Founder

Investors List

Burrill & Company
Burrill & Company investment in Series B - Cardiokine
Advent Venture Partners
Advent Venture Partners investment in Series B - Cardiokine
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Cardiokine

Care Capital
Care Capital investment in Series B - Cardiokine

Fidelity Biosciences
Fidelity Biosciences investment in Series B - Cardiokine
Ontario Teachers' Pension Plan
Ontario Teachers' Pension Plan investment in Series B - Cardiokine
HealthCare Ventures
HealthCare Ventures investment in Series B - Cardiokine

Perseus-Soros Biopharmaceutical Fund
Perseus-Soros Biopharmaceutical Fund investment in Series B - Cardiokine

CIBC Capital Partners
CIBC Capital Partners investment in Series B - Cardiokine
HealthCare Ventures
HealthCare Ventures investment in Series A - Cardiokine
